Based on end users the genomics market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users.
Partnerships and collaborations for technological advancements in genomics, and impact of COVID-19 on genomics increased the demand of genomics in market.
High cost of genomic instruments and the possibility of instrument obsolescence have driven end users to outsource their sequencing needs.
Contenders
Emerging Companies
Jul 2024
Yicai Global
